BA vs FDMT · P/E 89, rev $89.46B vs rev $37.0K
The Boeing Company (BA) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
BA currently screens at market cap $177.86B and trailing P/E 89.2. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the BA and FDMT stock pages for the full models.
Not investment advice.